Medinotec (MDNC) Cash from Financing Activities (2022 - 2026)
Medinotec (MDNC) posted Cash from Financing Activities of $25.0 for Q1 2026, up 100.99% on a QoQ basis from -$2531.0 in Q4 2025, and up 100.05% year-over-year from $12.5 in Q1 2025.
Medinotec (MDNC) Cash from Financing Activities (2022 - 2026) Analysis & Trends
Medinotec's Cash from Financing Activities history runs 5 years deep, the most recent figure standing at $25.0 for Q1 2026.
- Quarterly Cash from Financing Activities rose 100.05% year-over-year to $25.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was -$982973.0 (down 9.89% YoY) and the FY2026 annual result came in at -$982973.0, down 9.89% from the prior year.
- Cash from Financing Activities was $25.0 for Q1 2026 at Medinotec, up from -$2531.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $3.5 million in Q2 2022 and bottomed at -$942567.0 in Q3 2025.
- A 5-year average of $115811.5 and a median of -$2531.0 in 2025 frame the typical range for Cash from Financing Activities.
- Peak annual rise in Cash from Financing Activities reached 142.05% in 2024, while the deepest fall reached 797.66% in 2024.
- Medinotec's Cash from Financing Activities stood at $328214.0 in 2022, then plunged by 265.58% to -$543453.0 in 2023, then jumped by 79.82% to -$109684.0 in 2024, then surged by 97.69% to -$2531.0 in 2025, then surged by 100.99% to $25.0 in 2026.
- Business Quant data shows MDNC's Cash from Financing Activities at $25.0 in Q1 2026, -$2531.0 in Q4 2025, and -$942567.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 25.00 |
| Feb 28, 2026 | 25.00 |
| Nov 30, 2025 | -2,531.00 |
| Nov 30, 2025 | -2,531.00 |
| Aug 31, 2025 | -942,567.00 |
| Aug 31, 2025 | -942,567.00 |
| May 31, 2025 | -37,900.00 |
| May 31, 2025 | -37,900.00 |
| Feb 28, 2025 | -50,927.00 |
| Feb 28, 2025 | -50,927.00 |
| Nov 30, 2024 | -109,684.00 |
| Nov 30, 2024 | -109,684.00 |
| Aug 31, 2024 | -192,330.00 |
| Aug 31, 2024 | -192,330.00 |
| May 31, 2024 | -541,541.00 |
| May 31, 2024 | -541,541.00 |
| Feb 29, 2024 | 274,460.00 |
| Feb 29, 2024 | 274,460.00 |
| Nov 30, 2023 | -543,453.00 |
| Nov 30, 2023 | -543,453.00 |